Lexaria Bioscience Corp.
LEXX · NASDAQ
8/31/2025 | 8/31/2024 | 8/31/2023 | 8/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$11,911 | -$5,809 | -$6,713 | -$7,384 |
| Dep. & Amort. | $88 | $76 | $145 | $141 |
| Deferred Tax | $0 | $0 | -$158 | $0 |
| Stock-Based Comp. | $859 | $492 | $170 | $753 |
| Change in WC | $0 | $107 | $143 | -$351 |
| Other Non-Cash | $514 | $175 | $530 | $1,962 |
| Operating Cash Flow | -$10,450 | -$4,959 | -$5,881 | -$4,879 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | -$34 | -$131 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | -$243 | -$189 | -$136 | -$49 |
| Investing Cash Flow | -$243 | -$189 | -$170 | -$181 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | -$45 |
| Stock Issued | $0 | $4,209 | $1,590 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $6,046 | $6,106 | $0 | $0 |
| Financing Cash Flow | $6,046 | $10,315 | $1,590 | -$45 |
| Forex Effect | -$51 | -$20 | $0 | $0 |
| Net Chg. in Cash | -$4,698 | $5,148 | -$4,461 | -$5,105 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $6,500 | $1,352 | $5,813 | $10,918 |
| End Cash | $1,802 | $6,500 | $1,352 | $5,813 |
| Free Cash Flow | -$10,450 | -$5,002 | -$6,051 | -$5,011 |